Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-07-31 16:34:49 ET · period of report 2026-07-29 · accession 0001337798-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 16:34 | 2026-07-29 | KNSA | Cole G Bradley | Dir | S - Sale | $81.43 | -3,673 | 11.7K | -24% | -$299.1K | |
| 2026-07-31 16:34 | 2026-07-29 | KNSA | Cole G Bradley | Dir | G - Gift | $0.00 | -4,500 | 7,172 | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-07-29 | S | D | 3,673 | $81.43 | 11,672 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2026-07-29 | G | D | 4,500 | $0.00 | 7,172 | D | — | — | (F1) This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund. |